学习与工作经历：

1996.9-2001.07大学本科 医学学士学位 青岛大学 临床医学

2003.9-2006.06 硕士研究生 医学硕士学位 山东大学 急诊医学

2009.9-2013.06博士研究生 医学博士学位 山东大学 急诊医学

2006.7至今 山东大学齐鲁医院急诊科

研究方向：

致力于心血管重症的诊治，从事冠心病介入治疗16年，完成复杂高危介入手术破千例（如左主干病变、钙化病变、慢性闭塞病变等）。国外访学期间深入研究机械装置辅助下（IABP、IMPELLA及ECMO等）介入治疗。目前担任齐鲁医院急诊ECMO小组和肺血管急诊介入组负责人，作为主持者完成厅级课题2项/省级课题2项/国家级课题1项。第一作者或通讯作者在国内外医学杂志和会议上发表相关论文20余篇，其中SCI源刊10篇

学术/社会兼职：

中华医学会急诊医学分会生命支持学组委员；山东省医学会急诊分会胸痛学组副组长；山东省疼痛学会胸痛专委会副主任委员等。国家冠脉培训基地冠心病介入导师，美国哈佛医学院访问学者，美国克利夫兰心脏中心访问学者，美国哈特福德医院访问学者

获奖荣誉：

本科生课程：

研究生课程：

ALDH2－Nrf2 交互促控通过 NLRP3 炎症小体抑制巨噬细胞焦亡及动脉粥样硬化进展的作用及机制研究，山东省科技厅，2021.11， 10.00万，主持人

智能ECMO设备研发横向项目，山东恒心医疗公司，2021.11 ，50.00万，主持人

ECMO 心肺导流区流场优化及循环管路抗凝血涂层材料与技术的研发 山东大学齐鲁医学院，2022.10，50.00万，主持人

1、Yue XL, Shi XY, Jiang M, Li RJ. Acute pulmonary embolism presenting with electrocardiographic signs and serum biomarkers of ST-segment elevation myocardial infarction: a case report. J Int Med Res. 2023 Sep;51(9):3000605231197063.

2、Shi XY, Yue XL, Xu YS, Jiang M, Li RJ. Aldehyde dehydrogenase 2 and NOD-like receptor thermal protein domain associated protein 3 inflammasome in atherosclerotic cardiovascular diseases: A systematic review of the current evidence. Front Cardiovasc Med. 2023 Feb 23;10:1062502. doi: 10.3389/fcvm.2023.1062502. PMID: 36910525; PMCID: PMC9996072.

3、Lv X, Liu C, Zhang Y, Li R, Cao G. Anomalous Double Blood Supply to the Anterior Descending (LAD, RAD) Artery in an Infective Endocarditis Patient: A Case Report. Heart Surg Forum. 2022 Sep 12;25(5):E630-E633. doi: 10.1532/hsf.4863. PMID: 36317910.

4、Jiang M, Sun M, Zhang X, Luan XR, Li RJ. Disaster Nursing Competency of Intensive Care Nurses in Jinan, China: A Multicenter Cross-Sectional Study. J Nurs Res. 2022 Jun 1;30(3):e207. doi: 10.1097/jnr.0000000000000492. PMID: 35446276.

5、Jiang M, Sun M, Zhang X, Li R. Nutritional status and its association with in-hospital major adverse cardiac events in patients with severe heart failure: a prospective study. Nutr Hosp. 2022 Mar 29;39(2):256-265. English. doi: 10.20960/nh.03846. PMID: 35075911.

6、Ai W, Bae S, Ke Q, Su S, Li R, Chen Y, Yoo D, Lee E, Jon S, Kang PM. Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice. J Am Heart Assoc. 2021 Oct 19;10(20):e021212. doi: 10.1161/JAHA.121.021212. Epub 2021 Oct 8. PMID: 34622671; PMCID: PMC8751875.

7、Li R, Rhee SJ, Bae S, Su S, Kang CS, Ke Q, Koo YE, Ryu C, Song CG, Lee D, Kang PM. H2O2-Responsive Antioxidant Nanoparticle Attenuates Whole Body Ischemia/Reperfusion-Induced Multi-Organ Damages. J Cardiovasc Pharmacol Ther. 2021 May;26(3):279-288. doi: 10.1177/1074248420969571. Epub 2020 Oct 28. PMID: 33111565.

8、Xu Y, Yuan Q, Cao S, Cui S, Xue L, Song X, Li Z, Xu R, Yuan Q, Li R. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress. Biochem Biophys Res Commun. 2020 Sep 3;529(4):998-1004. doi: 10.1016/j.bbrc.2020.06.075. Epub 2020 Jul 30. PMID: 32819611.

9、Li R, Cui S, Xu Y, Xing J, Xue L, Chen Y. The upregulated scavenger receptor CD36 is associated with the progression of nontarget lesions after stent implantation in atherosclerotic rabbits. J Inflamm Res. 2018 Nov 13;11:447-456. doi: 10.2147/JIR.S179814. PMID: 30519072; PMCID: PMC6239100.

10、Wu JH, Hao PP, Chen YG, Li RJ. Intracoronary Glycoprotein IIb/IIIa Inhibitors Improve Short-Term Mortality and Reinfarction in East Asian Patients with ST-Segment Elevation Myocardial Infarction after Thrombus Aspiration: A Meta-Analysis. Evid Based Complement Alternat Med. 2018 Aug 15;2018:5174714. doi: 10.1155/2018/5174714. PMID: 30186355; PMCID: PMC6114074.

11、Li RJ, Ji WQ, Pang JJ, Wang JL, Chen YG, Zhang Y. Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome. Tohoku J Exp Med. 2013 Jan;229(1):45-51. doi: 10.1620/tjem.229.45. PMID: 23238616.